A Genetic System for Tissue-Specific Inhibition of Cell Proliferation.

Wenjuan Pu,Ximeng Han,Lingjuan He,Yan Li,Xiuzhen Huang,Mingjun Zhang,Zan Lv,Wei Yu,Qing-Dong Wang,Dongqing Cai,Jinjin Wang,Ruilin Sun,Jian Fei,Yong Ji,Yu Nie,Bin Zhou
DOI: https://doi.org/10.1242/dev.183830
IF: 6.8622
2020-01-01
Development
Abstract:Cellular proliferation is a basic process during organ development, tissue homeostasis, and/or disease progression. Likewise, after injury typically multiple cell lineages respond to various cues and proliferate to initiate repair and/or remodeling of the injured tissue. Unravelling the specific role of proliferation of one cell type and its lineage in the context of the whole organism during tissue regeneration and/or disease progression would provide valuable information on these processes. Here we reported a new genetic system to inhibit cell proliferation in a tissue-specific manner. We generated Cre- or Dre-inducible p21-GFP (ip21-GFP) transgenic mice that allow for the experimentally-induced permanent cell cycle arrest of specific cell lineages of interest, while genetically marking these cells. This system allows for the inhibition of pathogenic cell proliferation. We found that cardiac fibroblast proliferation inhibition significantly reduced scar formation, and promoted neovascularization and cardiomyocyte survival. Additionally, we found that inhibition of one type of cell proliferation (namely, hepatocytes) induces the lineage conversion of another type cells (ie, ductal cells) during tissue regeneration. These results validate the use of ip21-GFP mice as a new genetic tool for cell lineage-specific inhibition of cell proliferation in vivo.
What problem does this paper attempt to address?